(S)-3-((3S,6S)-3-((2S,3S)-2-acetamido-3-methylpentanamido)-4-oxo-1,2,3,4,6,7-hexahydroazepino[3,2,1-hi]indole-6-carboxamido)-4-oxobutanoic acid

ID: ALA428244

PubChem CID: 44453610

Max Phase: Preclinical

Molecular Formula: C25H32N4O7

Molecular Weight: 500.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@H]1CCc2cccc3c2N(C1=O)[C@H](C(=O)N[C@H](C=O)CC(=O)O)C3

Standard InChI:  InChI=1S/C25H32N4O7/c1-4-13(2)21(26-14(3)31)24(35)28-18-9-8-15-6-5-7-16-10-19(29(22(15)16)25(18)36)23(34)27-17(12-30)11-20(32)33/h5-7,12-13,17-19,21H,4,8-11H2,1-3H3,(H,26,31)(H,27,34)(H,28,35)(H,32,33)/t13-,17-,18-,19-,21-/m0/s1

Standard InChI Key:  PHKDXBRYQQCBAI-RUHZZDLRSA-N

Molfile:  

     RDKit          2D

 36 38  0  0  1  0  0  0  0  0999 V2000
    9.8743  -27.2200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2855  -27.8330    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4028  -28.6293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6991  -27.3121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1269  -28.0132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8330  -28.8183    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0842  -29.0671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3438  -27.3103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9325  -26.5975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1062  -26.6003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9329  -28.0216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.5244  -29.2824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1867  -28.8004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7095  -29.0766    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.9812  -29.8857    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5401  -30.1073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8337  -30.5334    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.2624  -30.5061    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.9688  -30.0800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6911  -30.4789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9531  -29.2552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6597  -28.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6439  -28.0043    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3819  -29.2281    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.3976  -30.0529    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.9756  -28.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2824  -29.1472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9348  -27.8759    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.5483  -28.7705    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3231  -29.9713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6298  -30.4185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0571  -30.3479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0978  -31.1719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5076  -27.9464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7736  -27.5698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2009  -27.4992    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
 16 18  1  0
  8  9  2  0
 18 19  1  0
  2  3  1  0
 19 20  1  0
  9 10  1  0
 19 21  1  1
 10  4  2  0
 21 22  1  0
 11  5  2  0
 22 23  2  0
  1  4  1  0
 22 24  1  0
  5  6  1  0
 20 25  2  0
  6  7  1  0
 14 26  1  0
  6 12  1  0
 26 27  1  0
 12 13  1  0
 26 28  2  0
 13 11  1  0
 27 29  1  6
  7  3  1  0
 27 30  1  0
  3 14  1  1
 30 31  1  6
  4  5  1  0
 30 32  1  0
  7 15  2  0
 32 33  1  0
 29 34  1  0
 12 16  1  1
 34 35  1  0
 11  8  1  0
 34 36  2  0
 16 17  2  0
M  END

Associated Targets(Human)

GZMB Tchem Granzyme B (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 500.55Molecular Weight (Monoisotopic): 500.2271AlogP: 0.08#Rotatable Bonds: 10
Polar Surface Area: 161.98Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.70CX Basic pKa: CX LogP: -0.15CX LogD: -3.45
Aromatic Rings: 1Heavy Atoms: 36QED Weighted: 0.33Np Likeness Score: 0.28

References

1. Maryanoff BE, Costanzo MJ..  (2008)  Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality.,  16  (4): [PMID:18053726] [10.1016/j.bmc.2007.11.015]

Source